Brokers Suggest Investing in Leidos (LDOS): Read This Before Placing a Bet

Leidos (LDOS) currently carries an Average Brokerage Recommendation (ABR) of 1.71, approximating a Strong Buy/Buy consensus, with 64.7% of analyst ratings at Strong Buy. While this ABR suggests a positive outlook, the article cautions against relying solely on such recommendations due to inherent positive bias, instead advocating for the Zacks Rank as a more reliable indicator based on earnings estimate revisions. Leidos's Zacks Rank #2 (Buy) is supported by a 6% increase in its current year consensus EPS estimate to $11.07 over the past month, suggesting its Buy-equivalent ABR could be useful when validated by this proprietary metric.

Analysis

Leidos (LDOS) exhibits strong positive sentiment from both sell-side analysts and quantitative models, though the latter is presented as a more reliable indicator. The stock currently holds an Average Brokerage Recommendation (ABR) of 1.71 on a 1-to-5 scale, positioning it between a Buy and a Strong Buy. This consensus is derived from 17 brokerage firms, with a significant 64.7%, or 11 analysts, rating the stock as a Strong Buy. More importantly, this analyst optimism is corroborated by fundamental momentum in the company's earnings outlook. The Zacks Consensus Estimate for current-year earnings per share has increased by 6% over the last month to $11.07. According to the provided framework, this trend in positive earnings estimate revisions is a more powerful predictor of near-term stock performance and is the primary reason for the stock's Zacks Rank #2 (Buy). The alignment between the qualitative analyst ratings and the quantitative earnings-driven rank strengthens the bullish case for the stock.

Key Decisions for Investors

• Investors should consider the recent 6% upward revision in the consensus EPS estimate to $11.07 as the primary bullish signal, as this is highlighted as a stronger predictor of near-term price movement than analyst ratings alone.
• The strong ABR of 1.71, with 64.7% of analysts issuing a 'Strong Buy', can serve as a valuable confirmation of a bullish thesis, but should not be the sole basis for an investment decision given the noted potential for inherent positive bias in sell-side ratings.
• Given that the positive outlook is heavily tied to earnings momentum, it is crucial to monitor for any future changes or slowdowns in earnings estimate revisions, as this would likely alter the stock's near-term prospects.